129 related articles for article (PubMed ID: 9394852)
1. A review of endocrine options for the treatment of advanced breast cancer.
Kaufmann M
Oncology; 1997; 54 Suppl 2():2-5. PubMed ID: 9394852
[TBL] [Abstract][Full Text] [Related]
2. Update on endocrine therapy for breast cancer.
Buzdar AU; Hortobagyi G
Clin Cancer Res; 1998 Mar; 4(3):527-34. PubMed ID: 9533518
[TBL] [Abstract][Full Text] [Related]
3. Aromatase inhibitors for breast cancer: pharmacoeconomic considerations.
Higa GM
Expert Opin Pharmacother; 2001 Jun; 2(6):987-95. PubMed ID: 11585014
[TBL] [Abstract][Full Text] [Related]
4. Proper sequence of endocrine therapies in advanced breast cancer.
Rose C
Acta Oncol; 1996; 35 Suppl 5():44-9. PubMed ID: 9142964
[TBL] [Abstract][Full Text] [Related]
5. Endocrine therapies of breast cancer.
Goldhirsch A; Gelber RD
Semin Oncol; 1996 Aug; 23(4):494-505. PubMed ID: 8757275
[TBL] [Abstract][Full Text] [Related]
6. [Aromatase inhibitors--new possibilities in treatment of breast carcinoma].
Friedrichs K; Jänicke F
Praxis (Bern 1994); 1998 Apr; 87(17):584-8. PubMed ID: 9623325
[TBL] [Abstract][Full Text] [Related]
7. Aromatase inhibitors in breast cancer: an update.
Lake DE; Hudis C
Cancer Control; 2002; 9(6):490-8. PubMed ID: 12514567
[TBL] [Abstract][Full Text] [Related]
8. Aromatase inhibitors in breast cancer: current and evolving roles.
Hill J; Moore H
Cleve Clin J Med; 2002 Jul; 69(7):561-7. PubMed ID: 12109640
[TBL] [Abstract][Full Text] [Related]
9. Changes in endocrine therapy: anastrozole and advanced breast cancer in postmenopausal women.
Nabholtz JM
Am J Hosp Palliat Care; 2004; 21(6):457-65. PubMed ID: 15612238
[TBL] [Abstract][Full Text] [Related]
10. Hormonal therapy in postmenopausal women with breast cancer.
Campos SM; Winer EP
Oncology; 2003; 64(4):289-99. PubMed ID: 12759523
[TBL] [Abstract][Full Text] [Related]
11. The role of selective non-steroidal aromatase inhibitors in future treatment strategies.
Blamey RW
Oncology; 1997; 54 Suppl 2():27-31. PubMed ID: 9394858
[TBL] [Abstract][Full Text] [Related]
12. Endocrine treatment options for advanced breast cancer--the role of fulvestrant.
Robertson JF; Come SE; Jones SE; Beex L; Kaufmann M; Makris A; Nortier JW; Possinger K; Rutqvist LE
Eur J Cancer; 2005 Feb; 41(3):346-56. PubMed ID: 15691633
[TBL] [Abstract][Full Text] [Related]
13. A comparison of fulvestrant and the third-generation aromatase inhibitors in the second-line treatment of postmenopausal women with advanced breast cancer.
Dodwell D; Vergote I
Cancer Treat Rev; 2005 Jun; 31(4):274-82. PubMed ID: 15908126
[TBL] [Abstract][Full Text] [Related]
14. Optimizing endocrine therapy for premenopausal and postmenopausal women with breast cancer.
Cianfrocca M; Wolff AC
Oncology (Williston Park); 2007 Jan; 21(1):63-9; discussion 69, 72, 75 passim. PubMed ID: 17313157
[TBL] [Abstract][Full Text] [Related]
15. Endocrine approaches for the treatment of early and advanced breast cancer in postmenopausal women.
Tobias JS
Int J Biochem Cell Biol; 2004 Nov; 36(11):2112-9. PubMed ID: 15313457
[TBL] [Abstract][Full Text] [Related]
16. Emerging role of aromatase inhibitors in the treatment of breast cancer.
Harvey HA
Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):32-5. PubMed ID: 9556789
[TBL] [Abstract][Full Text] [Related]
17. [Endocrine therapy for breast cancer: past and present].
Zhang Y; Liu Y
Zhonghua Yi Shi Za Zhi; 2015 Jan; 45(1):28-32. PubMed ID: 26268256
[TBL] [Abstract][Full Text] [Related]
18. Predicting benefit of endocrine therapy for early breast cancer.
Regan MM
Breast; 2015 Nov; 24 Suppl 2(0 2):S129-31. PubMed ID: 26255197
[TBL] [Abstract][Full Text] [Related]
19. The influence of endocrine treatments for breast cancer on health-related quality of life.
Buijs C; de Vries EG; Mourits MJ; Willemse PH
Cancer Treat Rev; 2008 Nov; 34(7):640-55. PubMed ID: 18514425
[TBL] [Abstract][Full Text] [Related]
20. Endocrine response after prior treatment with fulvestrant in postmenopausal women with advanced breast cancer: experience from a single centre.
Cheung KL; Owers R; Robertson JF
Endocr Relat Cancer; 2006 Mar; 13(1):251-5. PubMed ID: 16601292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]